loading

Relmada Therapeutics Inc (RLMD) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
43.90%
10.22
18.22 19.08 23.01 18.82
Operating Income/Loss
43.90%
-10.22
-18.22 -19.08 -23.01 -18.82
Nonoperating Income/Loss
46.15%
0.3549
0.659 0.4184 1.2829 1.0507
Income/Loss From Continuing Operations Before Tax
43.81%
-9.8664
-17.56 -18.66 -21.73 -17.77
Income/Loss From Continuing Operations After Tax
43.81%
-9.8664
-17.56 -18.66 -21.73 -17.77
Net Income/Loss
43.81%
-9.8664
-17.56 -18.66 -21.73 -17.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.15%
33.19
30.41 0.00351 30.17 30.17
Diluted Average Shares
9.15%
33.19
30.41 0.00351 30.17 30.17
Basic Earnings Per Share
48.28%
-0.30
-0.58 -0.62 -0.72 -0.59
Diluted Earnings Per Share
48.28%
-0.30
-0.58 -0.62 -0.72 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
大文字化:     |  ボリューム (24 時間):